When considered alongside the clinical, pathological, and gene enrichment data, we speculate that heightened GPD1L expression is prompted to sustain membrane GPL biosynthesis in rapidly proliferating, aggressive HCC tumours, contributing to an overall lipid metabolic reprogramming. This evidence concerns the gene GPD1L and hepatocellular carcinoma.